CAS: 36330-85-5; 4-([1,1'-Biphenyl]-4-yl)-4-Oxobutanoic Acid

该化合物是一种化学化合物,属于被称为苯尿素类的物质,主要被承认用于农业实践,特别是作为除草剂;该化合物显示有选择性的除草性活动,针对特定植物物种,同时尽量减少对他人的伤害,从而在作物管理中具有价值; Lederfen的功能,通过阻止植物中的某些生物化学途径,导致生长中断和最终造成植物死亡;从物理特性来看,该化合物在室内温度上一般是固体,具有中度溶解有机溶剂;安全和环境影响评估对于使用该化合物至关重要,因为许多农用化学品对确保尽可能减少对非目标有机体和生态系统的不利影响至关重要;适当处理和应用准则对于在保护人类健康和环境的同时最大限度地发挥功效至关重要.

结构式图片

欧盟法规

ECHA物质C&L通报REACH预注册

上下游产品

succinic acid anhydride biphenyl aluminium trichloride nitrobenzenebiphenyl-4-carboxylic acid 7-phenyl-3,4-dihydronaphthalen-1(2H)-one 5-([1,1'-biphenyl]-4-yl)-5-methyldihydrofuran-2(3H)-one 5-biphenyl-4-yl-3H-furan-2-one

合成工艺路线路线简述

  • 合成目标产物 Fenbufen 主要起始原料 Succinic Anhydride And Biphenyl
  • (文献来源)合成步骤主要原料 Succinic Anhydride 和 Biphenyl
Fenbufen Methyl Ester置于水,Sodium Hydroxide体系中,化学反应 2.0H,以99%的收率获得产物芬布芬
参考文献:未活化的脂肪族烯烃与有机卤化物的分子间还原性heck反应.
标题:未活化的脂肪族烯烃与有机卤化物的分子间还原性heck反应.
摘要:首先以高收率和完全的反马尔科夫尼科夫选择性实现了有机卤化物与末端和内部未活化的脂肪族烯烃的一般分子间还原性heck反应.首先应用了具有挑战性的乙烯基溴化物,芳基氯和多取代的内部烯烃.从易于获得的起始原料中快速合成了100多种远程碳官能化的烷基羧酸衍生物.药物分子的合成进一步证明了这种可扩展策略的广泛合成效用.初期机理研究与所提出的催化循环一致.
DOI:10.1021/acs.Orglett.9B04474

海关参考信息

专利信息


专利号:US-2024287520-A1
优先权日:2021-06-30
标题:Method for synthesis of linkage modified oligomeric compounds
发明人:RODRIGUEZ ANDREW A
权利人:IONIS PHARMACEUTICALS INC
摘要:The present disclosure provides methods of synthesizing modified oligonucletodies and oligomeric compounds (including oligomeric compounds that are antisense agents or portions thereof) comprising a modified oligonucleotide having at least one modified internucleoside linking group. In certain embodiments, the present disclosure provides stabilized formulations of certain sulfonyl azides for use in the synthesis of olignonucleotides comprising one or more sulfonyl phosphoramidate linkages. Some embodiments provide stabilized compositions of high energy reagents that may be used in the synthesis of modified oligonucleotides, allowing for safe process scale preparation thereof.

专利号:US-2004242897-A1
优先权日:2002-07-31
标题 :Universal support media for synthesis of oligomeric compounds
发明人:GUZAEV ANDREI P; MANOHARAN MUTHIAH
摘要:Compounds for the synthesis of oligomeric compounds, particularly oligonucleotides and oligonucleotide mimetics, are provided. In addition, methods for functionalizing a support medium with a first monomeric subunit and methods for the synthesis of oligomeric compounds utilizing the novel compounds bound to support media are provided.

专利号:US-2012177593-A1
优先权日:2009-07-20
标 题 :Synthesis of dendrimer conjugates
发明人:BAKER JR JAMES R; ZHANG YUEHUA; THOMAS THOMMEY P; DESAI ANKUR MAHESH
权利人:BAKER JR JAMES R; ZHANG YUEHUA; THOMAS THOMMEY P; DESAI ANKUR MAHESH; UNIV MICHIGAN
摘要:The present invention relates to novel methods of synthesis of therapeutic and diagnostic dendrimers. In particular, the present invention is directed to novel dendrimer conjugates, novel methods of synthesizing the same, compositions comprising the conjugates, as well as systems and methods utilizing the conjugates (e.g., in diagnostic and/or therapeutic settings (e.g., for the delivery of therapeutics, imaging, and/or targeting agents (e.g., in disease (e.g., cancer, inflammatory disease) diagnosis and/or therapy, pain therapy, etc.)). Accordingly, dendrimer conjugates of the present invention may further comprise at least two different components for targeting, imaging, sensing, and/or providing a therapeutic or diagnostic material and/or monitoring response to therapy. Furthermore, the novel synthesis methods of certain embodiments of the present invention provide significant advantages with regard to total reaction time and simplicity.

专利号:WO-2004011474-A1
优先权日:2002-07-31
标题:Universal support media for synthesis of oligomeric compounds
发明人:GUZAEV ANDREI P; MANOHARAN MUTHIAH; RAVIKUMAR VASULINGA T; KUMAR RAJU K
权利人:ISIS PHARMACEUTICALS INC; GUZAEV ANDREI P; MANOHARAN MUTHIAH; RAVIKUMAR VASULINGA T; KUMAR RAJU K
摘要:Compounds for the synthesis of oligomeric compounds, particularly oligonucleotide and oligonucleotide mimetics, are provided. In addition, methods for functionalizing a support medium with a first monomeric subunit and methods for the synthesis of oligomeric compounds utilizing the novel compounds bound to support media are provided.

专利号:US-6653468-B1
优先权日:2002-07-31
标 题 :Universal support media for synthesis of oligomeric compounds
发明人:GUZAEV ANDREI P; MANOHARAN MUTHIAH
权利人:ISIS PHARMACEUTICALS INC
摘要:Compounds for the synthesis of oligomeric compounds, particularly oligonucleotides and oligonucleotide mimetics, are provided. In addition, methods for functionalizing a support medium with a first monomeric subunit and methods for the synthesis of oligomeric compounds utilizing the novel compounds bound to support media are provided.

专利号:US-8546532-B2
优先权日:2008-04-17
标题:Synthesis of directed sequence polymer compositions and antibodies thereof for the treatment of protein conformational disorders
发明人:BONNIN DUSTAN; ZANELLI ERIC; MATHERS THOMAS
权利人:BONNIN DUSTAN; ZANELLI ERIC; MATHERS THOMAS; DECLION PHARMACEUTICALS INC
摘要:The instant invention comprises a process for the solid phase synthesis of directed epitope peptide mixtures useful in the treatment and diagnosis of protein conformational disorders, such process defined by a set of rules regarding the identity and the frequency of occurrence of amino acids that substitute a base or native amino acid of a known epitope. The resulting composition is a mixture of related peptides for therapeutic use. The invention also pertains to the process of generating antibodies using the directed epitope peptide mixtures as the antigens, and antibodies generated by such process, useful in the treatment and diagnostics of the said protein conformational disorder.
湖北恒硕化工有限公司
⚠️ 未注册 · 未认证企业
⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
数据来源于公开网络搜索,平台未作核实,请自行辨别。
🏢敬请 企业认领
🏬开设公司展台
📢获取免费会员权益
🎖️点亮专属注册企业标签
📇展现公司完整信息 样本查看立即注册认领 →
网址: http://www.hengshuochem.com
企业联系电话:027-82200625;82830253👤
📞湖北恒硕化工有限公司 ⚠️参考联系方式
联系人:王硕 徐文琪
电话:027-82200625;82830253
手机:13986271535;13995541600
传真:027-82830253
邮箱:hengshuochem@163.com
通信地址: 湖北省武汉市临空港经济技术开发区碧水大道7号飘轩工业园
邮编: 430014
🆔 联系时候可告知是从"百琢研"平台获取的信息.
⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

地址:湖北省武汉市临空港经济技术开发区碧水大道7号飘轩工业园
⚠️ 未注册 · 未认证企业
注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
湖北威德利化学科技有限公司
⚠️ 未注册 · 未认证企业
⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
数据来源于公开网络搜索,平台未作核实,请自行辨别。
🏢敬请 企业认领
🏬开设公司展台
📢获取免费会员权益
🎖️点亮专属注册企业标签
📇展现公司完整信息 样本查看立即注册认领 →
网址: http://www.widelychemical.com
企业联系电话:13385289472👤
📞湖北威德利化学科技有限公司 ⚠️参考联系方式
联系人:赵方
电话:13385289472
手机:13385289472
传真:027- 59222918
邮箱:z13385289472@163.com
通信地址: 湖北省武汉市硚口区解放大道204号
邮编: 430033
🆔 联系时候可告知是从"百琢研"平台获取的信息.
⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

地址:湖北省武汉市硚口区解放大道204号
⚠️ 未注册 · 未认证企业
注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
第 1 / 1 页

供应商参考报价(招募中)

品牌试剂参考报价(招募中)

📌 第三方产品分析报告

✅ COA系统入驻 | 共享模式

主要参考文献


1: Syed M, Skonberg C, Hansen SH. Inhibition of ATP synthesis by fenbufen and its conjugated metabolites in rat liver mitochondria. Toxicol In Vitro. 2016 Mar;31:23-9. doi: 10.1016/j.tiv.2015.11.013. Epub 2015 Nov 21. doi: 10.1016/j.jpba.2016.01.062. Epub 2016 Feb 1. doi: 10.1007/s10787-013-0194-4. Epub 2013 Nov 1. doi: 10.3390/molecules21030387. doi: 10.1016/j.saa.2012.09.034. Epub 2012 Sep 26. doi: 10.1016/j.biomaterials.2013.01.050. Epub 2013 Feb 4. doi: 10.3390/molecules15128796. doi: 10.1016/j.bmcl.2011.01.068. Epub 2011 Jan 22. doi: 10.1002/jps.22096. doi: 10.1002/14651858.CD007547.pub2. Review.

合成参考文献


参考文献:10.2165/11592550-000000000-00000
摘要:Altman RD, Barthel HR. Topical therapies for osteoarthritis. Drugs. 2011 Jul 09;71(10):1259–79. doi: 10.2165/11592550-000000000-00000.
📝 需求与反馈
尽可能描述清楚需求与问题信息
×

通知